You are here

AAVOGEN INC

Company Information
Address
13420 GLEN LEA WAY
POTOMAC, MD 20850-3638
United States


http://www.aavogen.com

Information

UEI: D7WBG8G7AWE4

# of Employees: 1


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: Yes



Award Charts




Award Listing

  1. Development of optimized adeno-associated viral capsids for muscle gene therapy

    Amount: $140,152.00

    PROJECT SUMMARY. Gene therapeutics offer hope to many patients with rare muscle and neuromuscular diseases. Despite some early successes, several serious off-target safety concerns have compromised th ...

    SBIRPhase I2023Department of Health and Human Services National Institutes of Health
  2. Preclinical Development of a Novel Gene Therapeutic for Inclusion Body Myositis

    Amount: $1,877,616.00

    PROJECT SUMMARY. Gene therapy offers hope to patients with sporadic inclusion body myositis (IBM). This chronic rare disease exclusively affects older adults and results from inflammation rather than ...

    SBIRPhase II2022Department of Health and Human Services National Institutes of Health
  3. Preclinical Validation of AVGN7 for Treating Duchenne Muscular Dystrophy

    Amount: $224,999.00

    PROJECT SUMMARYGene therapeutics offer hope to many patients with Duchenne muscular dystrophyDMDor with other neuromuscular degenerative diseasesAlthough successful in preclinical studiesnone of these ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  4. AVGN7, a Novel Gene Therapeutic for Treating Cancer Cachexia

    Amount: $2,002,000.00

    PROJECT SUMMARY. The skeletal muscle wasting that occurs with cancer cachexia compromises quality of life and is both directly and indirectly responsible for cancer mortalities. Tumor-derived and tumo ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government